FDG PET/CT findings of thymic carcinoid and bronchial carcinoid in a patient with multiple neuroendocrine neoplasia type1

Clinical Nuclear Medicine

Volumn 33, Issue 11, 2008, Pages 778-779

  Abe, Takashi ^a   Sato, Motohiro ^a   Okumura, Toshiyuki ^a   Shioyama, Yasukazu ^a   Kiyoshima, Moriyuki ^a   Asato, Yuji ^a   Saito, Hitoaki ^a   Iijima, Tatsuo ^a   Amemiya, Ryuta ^a   Nagai, Hideo ^a  

^a IBARAKI PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Bronchial carcinoid; Fluorine 18 fluorodeoxyglucose (F 18 FDG); Multiple endocrine neoplasia type 1 (MEN type1); Positron emission tomography computed tomography (PET CT); Thymic carcinoid

Indexed keywords

ALPHA FETOPROTEIN; CARCINOEMBRYONIC ANTIGEN; CHORIONIC GONADOTROPIN; FLUORODEOXYGLUCOSE F 18; IOPAMIDOL; TUMOR MARKER; MEN1 PROTEIN, HUMAN; ONCOPROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRONCHUS CARCINOID; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CARCINOID; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; GENETIC ANALYSIS; HUMAN; HYPERPARATHYROIDISM; HYPOGLYCEMIA; INCIDENCE; LYMPH NODE METASTASIS; MALE; MEDIASTINUM LYMPH NODE; MULTIPLE ENDOCRINE NEOPLASIA; POSITRON EMISSION TOMOGRAPHY; RADIODIAGNOSIS; THORAX RADIOGRAPHY; THYMIC CARCINOID; WHOLE BODY CT; BRONCHUS TUMOR; GENETIC MARKER; GENETICS; METASTASIS; METHODOLOGY; PATHOLOGY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; THYMOMA; WHOLE BODY IMAGING;

ADULT; BRONCHIAL NEOPLASMS; CARCINOID TUMOR; FLUORODEOXYGLUCOSE F18; GENETIC MARKERS; HUMANS; LYMPHATIC METASTASIS; MALE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; POSITRON-EMISSION TOMOGRAPHY; PROTO-ONCOGENE PROTEINS; SENSITIVITY AND SPECIFICITY; THYMUS NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING;

EID: 58149237162     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e318187efef     Document Type: Article

References (13)

1. Scarsbrook AF, Thakker RV, Wass JA, et al. Multiple endocrine neoplasia: spectrum of radiologic appearances and discussion of a multitechnique imaging approach. RadioGraphics. 2006;26:433-451.
2. Marx A, Shimosato Y, Kuo TT. Thymic neuroendocrine tumours. In: Travis WD, Brambilla E, Muller-Hrmelink HK, et al, eds. World Health Organization Classification of Tumours Pathology and Genetics Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press; 2003:188-195.
3. Gibril F, Chen Y-J, Schrump DS, et al. Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 2003;88:1066-1081.
4. Sachithanandan N, Harle RA, Burgess JR, Bronchopulmonary carcinoid in multiple endocrine neoplasia type 1. Cancer. 2005;103:509-515.
5. Chong S, Lee KS, Chung MJ, et al. Neuroendocrine tumors of the lung: clinical, pathologic, and imaging findings. RadioGraphics. 2006;26:41-58.
6. Markou A, Manning P, Kaya B, et al. 18F.fluoro-2-dewxy-D-glucose (18F.FDG) positron emission tomography imaging of thymic carcinoid tumor presenting with recurrent Cushing's syndrome. Eur J Endocrinol. 2005;152:521-525.
7. Groves AM, Mohan HK, Wegner EA, et al. Positron emission tomography with FDG to show thymic carcinoid. AJR Am J Roentgenol. 2004;182:511-513.
8. Whitaker D, Dussek J. PET scanning in thymic neuroendocrine tumors. Chest. 2004;125:2368-2369.
9. Semin C, Kyung SL, Byung-Tae K, et al. Integrated PET/CT of pulmonary neuroendocrine tumors. AJR Am J Roentgenol. 2007;188:1223-1231.
10. Kruger S, Buck AK, Blumstein NM, et al. Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumors. J Intern Med. 2006; 260:545-550.
11. Erasmus JJ, McAdams HP, Patz EF Jr, et al. Evaluation of primary pulmonary carcinoid tumors using FDG PET. AJR Am J Roentgenol. 1998;170:1369-1373.
12. Demura Y, Tsuchida T, Ishizaki T, et al. 18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax. J Nucl Med. 2003;44:540-548.
13. Nakamoto Y, Higashi T, Sakahara H, et al. Delayed 18F-Fluoro-"deoxy- D-glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas." Cancer. 2000;89: 2547-5442.